222 related articles for article (PubMed ID: 19015995)
21. High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan.
Altaf A; Saleem N; Abbas S; Muzaffar R
J Pak Med Assoc; 2009 Mar; 59(3):136-40. PubMed ID: 19288936
[TBL] [Abstract][Full Text] [Related]
22. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
23. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.
Tempalski B; Pouget ER; Cleland CM; Brady JE; Cooper HL; Hall HI; Lansky A; West BS; Friedman SR
PLoS One; 2013; 8(6):e64789. PubMed ID: 23755143
[TBL] [Abstract][Full Text] [Related]
24. Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas.
Tempalski B; Cleland CM; Pouget ER; Chatterjee S; Friedman SR
Subst Abuse Treat Prev Policy; 2010 Sep; 5():23. PubMed ID: 20858258
[TBL] [Abstract][Full Text] [Related]
25. HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia.
Mills HL; White E; Colijn C; Vickerman P; Heimer R
Drug Alcohol Depend; 2013 Nov; 133(1):242-7. PubMed ID: 23692991
[TBL] [Abstract][Full Text] [Related]
26. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
27. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.
Strathdee SA; Shoptaw S; Dyer TP; Quan VM; Aramrattana A;
Curr Opin HIV AIDS; 2012 Jul; 7(4):320-5. PubMed ID: 22498479
[TBL] [Abstract][Full Text] [Related]
28. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004.
Grigoryan A; Hall HI; Durant T; Wei X
PLoS One; 2009; 4(2):e4445. PubMed ID: 19214229
[TBL] [Abstract][Full Text] [Related]
29. Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China.
Hammett TM; Des Jarlais DC; Kling R; Kieu BT; McNicholl JM; Wasinrapee P; McDougal JS; Liu W; Chen Y; Meng D; Doan N; Tho HN; Quyen NH; Tren VH
PLoS One; 2012; 7(8):e43141. PubMed ID: 22952640
[TBL] [Abstract][Full Text] [Related]
30. CDC international HIV prevention research activities among injection drug users in Thailand and Russia.
Greenberg AE; Tappero J; Choopanya K; van Griensven F; Martin M; Vanichseni S; Santibanez S; Molotilov V; Hader S; Broyles LN
J Urban Health; 2005 Sep; 82(3 Suppl 4):iv24-33. PubMed ID: 16107437
[TBL] [Abstract][Full Text] [Related]
31. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
Vickerman P; Martin NK; Roy A; Beattie T; Jarlais DD; Strathdee S; Wiessing L; Hickman M;
Drug Alcohol Depend; 2013 Sep; 132(1-2):172-81. PubMed ID: 23453261
[TBL] [Abstract][Full Text] [Related]
32. Entry of human immunodeficiency virus infection into a population of injecting drug users, Victoria, 1990.
Crofts N; Hay M
Med J Aust; 1991 Sep; 155(6):378-82. PubMed ID: 1921786
[TBL] [Abstract][Full Text] [Related]
33. HIV infection among injection-drug users - 34 states, 2004-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(46):1291-5. PubMed ID: 19940834
[TBL] [Abstract][Full Text] [Related]
34. HIV prevalence and risk behavior among injection drug users and their sex partners in two Russian cities.
Eritsyan KU; Levina OS; White E; Smolskaya TT; Heimer R
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):687-90. PubMed ID: 23186172
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of HIV, sexually transmitted infections, and viral hepatitis by Urbanicity, among men who have sex with men, injection drug users, and heterosexuals in the United States.
Oster AM; Sternberg M; Nebenzahl S; Broz D; Xu F; Hariri S; Miles I; Paz-Bailey G
Sex Transm Dis; 2014 Apr; 41(4):272-9. PubMed ID: 24622641
[TBL] [Abstract][Full Text] [Related]
36. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India.
Hangzo C; Chatterjee A; Sarkar S; Zomi GT; Deb BC; Abdul-Quader AS
Addiction; 1997 Jul; 92(7):813-20. PubMed ID: 9293040
[TBL] [Abstract][Full Text] [Related]
37. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users.
Richter A; Brandeau ML; Owens DK
Med Decis Making; 1999; 19(2):167-79. PubMed ID: 10231079
[TBL] [Abstract][Full Text] [Related]
38. Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
Mathers BM; Degenhardt L; Adam P; Toskin I; Nashkhoev M; Lyerla R; Rugg D
J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S132-42. PubMed ID: 19901626
[TBL] [Abstract][Full Text] [Related]
39. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.
López-Zetina J; Ford W; Weber M; Barna S; Woerhle T; Kerndt P; Monterroso E
Sex Transm Infect; 2000 Dec; 76(6):462-9. PubMed ID: 11221130
[TBL] [Abstract][Full Text] [Related]
40. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
